Analyst Reco. Novartis AG

Equities

Market Closed - Swiss Exchange Other stock markets 16:31:30 26/04/2024 BST			5-day change	1st Jan Change
89.5 ^CHF	-0.56%		+4.64%	+5.46%

04-26	NOVARTIS AG : Receives a Buy rating from Jefferies	ZD
04-24	BMO Capital Adjusts Price Target on Novartis to $116 From $114, Maintains Market Perform Rating	MT

NOVARTIS AG : Receives a Buy rating from Jefferies	04-26	ZD
BMO Capital Adjusts Price Target on Novartis to $116 From $114, Maintains Market Perform Rating	04-24	MT
NOVARTIS AG : UBS reaffirms its Buy rating	04-24	ZD
NOVARTIS AG : Deutsche Bank gives a Buy rating	04-24	ZD
NOVARTIS AG : JP Morgan remains Neutral	04-24	ZD
NOVARTIS : 2024 has started on a strong note; guidance upgraded	04-23
NOVARTIS AG : JP Morgan gives a Neutral rating	04-23	ZD
NOVARTIS AG : Barclays keeps a Sell rating	04-23	ZD
NOVARTIS : Oddo BHF confirms its recommendation on the share	04-23	CF
NOVARTIS AG : UBS remains its Buy rating	04-23	ZD
NOVARTIS AG : Gets a Buy rating from Jefferies	04-23	ZD
Novartis Raises Guidance on Profit, Sales Growth -- Update	04-23	DJ
Novartis Raises Guidance on Profit, Sales Growth	04-23	DJ
NOVARTIS AG : UBS reiterates its Buy rating	04-18	ZD
NOVARTIS AG : Deutsche Bank maintains a Buy rating	04-18	ZD
Trending : Novartis Begins Tender Offer for MorphoSys Shares	04-11	DJ
NOVARTIS : UBS reiterates its recommendation on the stock	04-11	CF
NOVARTIS AG : UBS remains its Buy rating	04-10	ZD
NOVARTIS AG : Jefferies maintains a Buy rating	04-04	ZD
NOVARTIS AG : UBS reiterates its Buy rating	04-04	ZD